Guardian Pharmacy Services (GRDN) Cash & Current Investments (2023 - 2026)

Guardian Pharmacy Services' Cash & Current Investments history runs 4 years deep, the most recent figure standing at $64.9 million for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 363.55% year-over-year to $64.9 million; the TTM figure through Mar 2026 stood at $64.9 million (up 363.55% YoY), while the FY2025 annual figure was $65.6 million, up 1308.13% from the prior year.
• Cash & Current Investments came in at $64.9 million for Q1 2026 at Guardian Pharmacy Services, down from $65.6 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $65.6 million in Q4 2025 to a low of $752000.0 in Q4 2023.
• A 4-year average of $30.3 million and a median of $27.7 million in 2025 frame the typical range for Cash & Current Investments.
• On a YoY basis, Cash & Current Investments climbed as much as 1308.13% in 2025 and fell as far as 1.97% in 2025.
• Guardian Pharmacy Services' Cash & Current Investments stood at $752000.0 in 2023, then jumped by 519.68% to $4.7 million in 2024, then surged by 1308.13% to $65.6 million in 2025, then dropped by 1.11% to $64.9 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $64.9 million, $65.6 million, and $36.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison